PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Targeting the protein-making machinery to stop harmful bacteria

2014-09-07
(Press-News.org) One challenge in killing off harmful bacteria is that many of them develop a resistance to antibiotics. Researchers at the University of Rochester are targeting the formation of the protein-making machinery in those cells as a possible alternate way to stop the bacteria. And Professor of Biology Gloria Culver has, for the first time, isolated the middle-steps in the process that creates that machinery—called the ribosomes.

"No one had a clear understanding of what happened inside an intact bacterial cell," said Culver, "And without that understanding, it would not be possible to block ribosome formation as a new means of stopping bacterial growth."

Since proteins are essential for life, organisms would die-off if not allowed to manufacture proteins.

Culver's work has been published in Nature Structural and Molecular Biology.

Ribosomes are made of ribonucleic acid (RNA) and protein molecules that fit together like pieces of a puzzle. In order for the puzzle to work, the strands of RNA molecules need to be pared down to the right size. This multi-step process happens very quickly, making it difficult to capture a piece of ribosomal RNA in one of the intermediate states. Culver and graduate student Neha Gupta have managed to do just that by using genetic tags as markers inside E. coli cells.

By attaching the tags to non-functional regions of the uncut RNA, the researchers were able to isolate the immature RNA strands during the various stages of processing. On analyzing the intermediate fragments, Culver and Gupta found that ribosomal RNA does not follow a single sequential series of steps. While there appears to be an early common step, some of the intermediate RNA strands had started losing fragments from one side, while other intermediate RNAs at a similar stage were being cleaved from the other side. The different pathways of processing the RNA take place simultaneously among the various molecules, resulting in RNA strands being able to fit together with protein molecules to form fully-developed ribosomes.

Targeting ribosomes to kill drug-resistant bacteria is nothing new, except, in the past, scientists focused on mature ribosomes. While a range of antibiotics were developed to attack the ribosomes, the microbes eventually became resistant to those drugs.

While Culver's work creates new possibilities for stopping super-bugs, a great deal of work remains to be done.

"If bacterial cells have more than one way to make ribosomes, blocking just one pathway may not be enough to kill them." said Culver. "But our discoveries suggest that there is at least one common step that could be exploited to one day help scientists prevent the ribosomes from developing, which would kill off the bacteria." INFORMATION:


ELSE PRESS RELEASES FROM THIS DATE:

Continuing Bragg legacy of structure determination

2014-09-07
Over 100 years since the Nobel Prize-winning father and son team Sir William and Sir Lawrence Bragg pioneered the use of X-rays to determine crystal structure, University of Adelaide researchers have made significant new advances in the field. Published in the journal Nature Chemistry today, Associate Professors Christian Doonan and Christopher Sumby and their team in the School of Chemistry and Physics, have developed a new material for examining structures using X-rays without first having to crystallise the substance. "2014 is the International Year of Crystallography, ...

Ultraviolet light-induced mutation drives many skin cancers, Stanford researchers find

2014-09-07
A genetic mutation caused by ultraviolet light is likely the driving force behind millions of human skin cancers, according to researchers at the Stanford University School of Medicine. The mutation occurs in a gene called KNSTRN, which is involved in helping cells divide their DNA equally during cell division. Genes that cause cancer when mutated are known as oncogenes. Although KNSTRN hasn't been previously implicated as a cause of human cancers, the research suggests it may be one of the most commonly mutated oncogenes in the world. "This previously unknown oncogene ...

Ultra-thin, high-speed detector captures unprecedented range of light waves

Ultra-thin, high-speed detector captures unprecedented range of light waves
2014-09-07
New research at the University of Maryland could lead to a generation of light detectors that can see below the surface of bodies, walls, and other objects. Using the special properties of graphene, a two-dimensional form of carbon that is only one atom thick, a prototype detector is able to see an extraordinarily broad band of wavelengths. Included in this range is a band of light wavelengths that have exciting potential applications but are notoriously difficult to detect: terahertz waves, which are invisible to the human eye. A research paper about the new detector ...

Researchers discover a key to making new muscles

Researchers discover a key to making new muscles
2014-09-07
La Jolla, Calif., September 7, 2014 -- Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have developed a novel technique to promote tissue repair in damaged muscles. The technique also creates a sustainable pool of muscle stem cells needed to support multiple rounds of muscle repair. The study, published September 7 in Nature Medicine, provides promise for a new therapeutic approach to treating the millions of people suffering from muscle diseases, including those with muscular dystrophies and muscle wasting associated with cancer and aging. There ...

UK study identifies molecule that induces cancer-killing protein

2014-09-07
LEXINGTON, Ky. (Sept. 8, 2014) – A new study by University of Kentucky researchers has identified a novel molecule named Arylquin 1 as a potent inducer of Par-4 secretion from normal cells. Par-4 is a protein that acts as a tumor suppressor, killing cancer cells while leaving normal cells unharmed. Normal cells secrete small amounts of Par-4 on their own, but this amount is not enough to kill cancer cells. Notably, if Par-4 secretion is suppressed, this leads to tumor growth. Published in Nature Chemical Biology, the UK study utilized lab cultures and animal models ...

Each day in the hospital raises risk of multidrug-resistant infection

2014-09-07
If a patient contracts an infection while in the hospital, each day of hospitalization increases by 1% the likelihood that the infection will be multidrug-resistant, according to research presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) an infectious disease meeting of the American Society for Microbiology. Researchers from the Medical University of South Carolina gathered and analyzed historical data from 949 documented cases of Gram-negative infection at their academic medical center. In the first few days of hospitalization ...

New antifungal as effective as existing drugs with fewer adverse events

2014-09-07
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology. "There is a growing need for new antifungal therapies like isavuconazole because serious fungal infections caused by Aspergillus and other molds are on the rise due to the increasing numbers of immunosuppressed ...

Inexpensive lab test identifies resistant infections in hours

2014-09-07
Researchers from Oregon State Public Health Lab have modified the protocol for a relatively new test for a dangerous form of antibiotic resistance, increasing its specificity to 100 percent. Their research, confirming the reliability of a test that can provide results in hours and is simple and inexpensive enough to be conducted in practically any clinical laboratory was presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology. The test, called Carba NP, originally ...

61 percent fall in female genital warts due to free HPV vaccine

61 percent fall in female genital warts due to free HPV vaccine
2014-09-07
GPs in Australia are managing 61 per cent less cases of genital warts among young women since the introduction of the national human papillomavirus (HPV) vaccination program, a new study from the University of Sydney reveals. The study, which reviewed more than a million patient encounters between 2000 and 2012, showed a significant year-on-year reduction in the management rate of genital warts in women aged 15-27 years since the vaccination program started. The findings are published in PLOS One journal. "The results show that the program has been a widespread success," ...

Flour identified as the main cause of occupational asthma in France

2014-09-07
Munich, Germany: Flour has been identified as the main cause of occupational asthma in France, closely followed by cleaning products. A new study, which was presented at the European Respiratory Society's International Congress today (07 September 2014), analysed all cases of occupational asthma in France. The research, which is the largest of its kind to be undertaken in France, aimed to understand who was most affected by the condition and what the main causes were. Data were collected over a 3-year period from a network of respiratory doctors specialised in occupational ...

LAST 30 PRESS RELEASES:

New software sheds light on cancer’s hidden genetic networks

UT Health San Antonio awarded $3 million in CPRIT grants to bolster cancer research and prevention efforts in South Texas

Third symposium spotlights global challenge of new contaminants in China’s fight against pollution

From straw to soil harmony: International team reveals how biochar supercharges carbon-smart farming

Myeloma: How AI is redrawing the map of cancer care

Manhattan E. Charurat, Ph.D., MHS invested as the Homer and Martha Gudelsky Distinguished Professor in Medicine at the University of Maryland School of Medicine

Insilico Medicine’s Pharma.AI Q4 Winter Launch Recap: Revolutionizing drug discovery with cutting-edge AI innovations, accelerating the path to pharmaceutical superintelligence

Nanoplastics have diet-dependent impacts on digestive system health

Brain neuron death occurs throughout life and increases with age, a natural human protein drug may halt neuron death in Alzheimer’s disease

SPIE and CLP announce the recipients of the 2025 Advanced Photonics Young Innovator Award

Lessons from the Caldor Fire’s Christmas Valley ‘Miracle’

Ant societies rose by trading individual protection for collective power

Research reveals how ancient viral DNA shapes early embryonic development

A molecular gatekeeper that controls protein synthesis

New ‘cloaking device’ concept to shield sensitive tech from magnetic fields

Researchers show impact of mountain building and climate change on alpine biodiversity

Study models the transition from Neanderthals to modern humans in Europe

University of Phoenix College of Doctoral Studies releases white paper on AI-driven skilling to reduce burnout and restore worker autonomy

AIs fail at the game of visual “telephone”

The levers for a sustainable food system

Potential changes in US homelessness by ending federal support for housing first programs

Vulnerability of large language models to prompt injection when providing medical advice

Researchers develop new system for high-energy-density, long-life, multi-electron transfer bromine-based flow batteries

Ending federal support for housing first programs could increase U.S. homelessness by 5% in one year, new JAMA study finds

New research uncovers molecular ‘safety switch’ shielding cancers from immune attack

Bacteria resisting viral infection can still sink carbon to ocean floor

Younger biological age may increase depression risk in older women during COVID-19

Bharat Innovates 2026 National Basecamp Showcases India’s Most Promising Deep-Tech Ventures

Here’s what determines whether your income level rises or falls

SCIE indexation achievement: Celebrate with Space: Science & Technology

[Press-News.org] Targeting the protein-making machinery to stop harmful bacteria